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Hui Wang, Xiang Wang*, Cheng-Feng Wang for 58.4%-74.6%, 15.0%-16.1% and 9.3%-31% of all phyllodes tumors (Tan et al., 2005; Taira et al., 2007; Karim et al., 2009) , and the recurrence rate for three groups is 10%-17%, 14%-25%, 23-30% (Rowell et al., 1993) , respectively. Of malignant tumors 1/3 to 1/2 will metastasize (Reinfuss et al., 1996) .
Phyllodes tumors are well-circumscribed , painless, mobile masses that are surrounded by a pseudocapsule of compressed breast parenchyma (Rowell et al., 1993) . Sometimes, lesion grows suddenly and dilated veins may be observed overlying large phyllodes tumors. Microscopically, PT contains both epithelial and stromal components. The stroma is much more cellular and contains nuclear atypia and mitotic activity, which differs from fibroadenoma.
PT has an overall good prognosis, while local recurrence is a common problem. Surgery is the standard treatment for PT. Generally, local excision is taken in benign and small tumors, while total mastectomy will be taken into account when it is borderline, huge, malignant or repeatedly recurrent. Axillary lymph node involvements are described in fewer than 5% of all patients with phyllodes tumors (Belkacemi et al., 2008; SuzukiUematsu et al., 2010) , otherwise, malignant PTs are bloodvessle-borne metastasis, so routine axillary lymph node dissection seems unnecessary, unless there is certain metastasies or clinical palpable lymph node. Although the histologic type is an established independent prognostic factor for survival (Chaney et al., 2000) , the prognostic value of other parameters remains uncertain. Moreover, there are no definite predisposing factors and the etiology of phyllodes tumor is not clearly known. In this study, we aim to identify the difference in clinical features between benign, borderline and malignant phyllodes tumors and help to better explore this rare disease in the future.
Materials and Methods
Patients
Data from 246 women with PT of the breast treated in Cancer Hospital Chinese Academy of Medical Sciences between 2002 and 2012 was collected and analyzed retrospectively with a follow-up to May 20th, 2014, including age, tumor size, location, histological type, way of surgery and treatment, DFS. all of the patients are female. Of all of them, 61 patients have recurrence and one person has both local recurrence and distant metastasis. According to the World Health Organization classification (Tan et al., 2005) there are 125 (55%)benign, 55 (24%) borderline and 47 (21%) malignant cases in our study, respectively. 181 cases had complete followup. Follow-up data was obtained by telephone call and records of re-examination. The pathological diagnosis of intial neoplasms was fibroadenoma in 14 patients. Four patients with malignant PT died of distant metastases, 2 lung and 2 intial bone metastases.
Pathological methods
A pathological consultation will be performed when the masses are first resected not by our hospital. Patients with intial PT treated in our center are diagnosed by core needle biopsy or fast intraoperative frozen HaematoxylinEosin staining at first. Then after the operation, a routine paraffin pathology will be given to reassure the result. The pathological sections before 2003 are reviewed again to ensure a consistent application of standard histologic criteria.
Statistical analysis
Statistical analysis was carried out by SPSS, version 17.0. Differences in clinical features between three groups were assessed by the log-rank Pearson Chi-square test, Fisher exact test, ANOVA and Nonparametric Test. The P Univariate analyses identified that average age at presentation, average age at treatment, size of primary tumor, ulceration or not, type of primary surgery, distant metastasis and number of mitosis per 10 hpf are statistically different in three PT types (p=0.014, 0.018, <0.000, 0.003, <0.000, 0.001 and <0.000, respectively), while recurrence and disease-free survival (DFS) demonstrate a trend of statistical significance ( P =0.055 and 0.060, respectively), as is shown in Table 3 .
Course=age at treatment-age at presentation, otherwise, recurrence includes both local recurrence and distant metastasis. So there is colineary in these parameters. We can see from multivariate analysis in Table 4 distant metastasis and excision are significantly different in benign, borderline and malignant phyllodes tumors of the breast (p=0.041 and 0.018, OR=0.061 and 0.051). At the same time, size of primary tumor with p=0.052 tends to be different in groups (OR=1.127). However, age at treatment, ulceration and DFS demonstrate no statistical significance in three groups (p=0.400, 0.286 and 0.413, respectively). 
Discussion
In our study, we found malignant phyllodes tumors were more likely to be bigger and develop distant metastasis comparing benign and borderline (p=0.052, OR=1.127 and p=0.041, OR=0.061, respectively). We also noted a trend toward more excision cases in benign patients (p=0.018, OR=0.051). Apart from stromal hypercellularity, mitoses, cytologic atypia, stromal overgrowth and tumor borders, which are categorical standard items, several authors have noted (Tan et al., 2005; Barrio et al., 2007) other histological characteristics, such as necrosis, hemorrhage, cystic degeneration, intratumoral pseudoangiomatous stromal hyperplasia etc, are different in three histologic PTs. Our study aims to find the differences in clinical features between benign borderline and malignant phyllodes tumors, so we excludes count of mitosis in Ordinal Logistic Regression Analysis.
The current series had 61 recurrent cases, including 56 local control failures, 6 distant metastases and 1 concurrent recurrence. The local recurrence rate for three groups were 18%, 29% and 25% (p=0.326), while distant metastases rate were 0, 2% and 14% (p=0.001). That is, benign borderline and malignant phyllodes tumors have different distant metastases, but not local recurrence. Jing Wei et al. in his study of 192 cases also states histotype is related with distant metastasis (p<0.001), while has no relationship with local recurrence (p=0.139) (Wei et al., 2014) .
The mean size of primary tumor for three groups were 3.7, 4.8 and 7.5cm in univariate analysis with p<0.000. On multivariate analysis, patients with bigger masses are more likely to be malignant (p=0.052, OR=1.127). A retrospective study carried out by Memorial SloanKettering Cancer Center in 2007 (Barrio et al., 2007) categorized phyllodes tumors into benign and malignant (including borderline and malignant) groups and tumor size into ≤3.0cm and >3.0cm, and they found malignant group was bigger than benign group (p<0.0001), so as another research done by Puay-Hoon Tan et al. with p<0.001 (Tan et al., 2005) .
From the univariate analysis in our study, we can see benign phyllodes tumors accounts for 63% (121/192) excision, and the rates for borderline and malignant are 24% (46/192) and 13% (25/192) , respectively. In mastectomy group, the constitute rates for benign borderline and malignant are 8% (2/26), 27% (7/26) and 65% (17/26) with p<0.000. That is benign phyllodes tumors are more likely to choose excision, however, for the malignant, mastectomy is favored. In the literature and NCCN (August et al., 2000; Hassouna et al., 2006; NCCN, 2014) , the primary goal for treatment of phyllodes tumor is to achieve wide negative margin (tumor cells are present≥1cm from the closest surgical margin), mastectomy is recommended for malignant PT, which has worse prognosis, whereas for borderline and benign PT, treatment is based on wide local excision. In daily clinical work, we just treat PT mainly according to this standard. On multivariate analysis, excision (p=0.018, OR=0.051) is statistically significant, which from the other side proves our data is real and accurate.
From table 3, we can see average age at treatment is different in three groups, but in multivariate analysis this parameter doesn't show any statistical significance. A study including 363 cases undertook in Pakistan found the frequency of phyllodes tumor in adolescent girls and young women (less than and equal to 25 years of age) were identical (Khurshid et al., 2006) . From these data, we can see benign, borderline and malignant PT have no difference in age and there is an equal distribution of three PTs in the population. In light of the rarity of this disease, large multi-center studies are needed to further confirm our findings.
In summary, besides histopathologic characteristics, benign borderline and malignant phyllodes tumors are different in clinical features, such as primary tumor size, distant metastasis and surgical procedure. Efforts should be made to explore the unpredictable performance of three histologic PTs and help to better know and treat further this rare disease.
